Pages that link to "Q44983950"

The following pages link to Rosiglitazone does not improve vascular function in subjects with chronic kidney disease. (Q44983950):

Displaying 16 items.

• Efficacy and safety of thiazolidinediones in diabetes patients with renal impairment: a systematic review and meta-analysis (Q33687578) (← links)
• Arterial stiffness and cardiovascular therapy (Q34079790) (← links)
• Effects of thiazolidinedione therapy on inflammatory markers of type 2 diabetes: a meta-analysis of randomized controlled trials (Q35510830) (← links)
• Thiazolidinediones improve flow-mediated dilation: a meta-analysis of randomized clinical trials. (Q35874542) (← links)
• Insulin resistance and vascular dysfunction in chronic kidney disease: mechanisms and therapeutic interventions (Q38587721) (← links)
• Do Advanced Glycation End Products and Its Receptor Play a Role in Pathophysiology of Hypertension? (Q39158946) (← links)
• The impact of chronic kidney disease and short-term treatment with rosiglitazone on plasma cell-free DNA levels (Q42068501) (← links)
• Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease. (Q43660294) (← links)
• IL-1 Inhibition and Vascular Function in CKD. (Q48040831) (← links)
• Renal function preservation with pioglitazone or with basal insulin as an add-on therapy for patients with type 2 diabetes mellitus (Q48089786) (← links)
• Insulin resistance in chronic kidney disease (Q49859006) (← links)
• Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease (Q57688763) (← links)
• Effect of Vitamin D on Endothelial Function and Blood Pressure (Q61853230) (← links)
• PPARγ and Its Agonists in Chronic Kidney Disease (Q90219748) (← links)
• Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence (Q90722135) (← links)
• Lipid Accumulation and Chronic Kidney Disease (Q92702386) (← links)